Reversal of 5-flouroucial resistance by adenovirus-mediated transfer of wild-type p53 gene in multidrug-resiatant human colon carcinoma LoVo/5-FU cells

被引:7
作者
Yu, Zhi-Wei [1 ]
Zhao, Peng [1 ]
Liu, Ming [1 ]
Dong, Xin-Shu [1 ]
Tao, Ji [2 ]
Yao, Xue-Qin [3 ]
Yin, Xin-Hua [4 ]
Li, Yu [5 ]
Fu, Song-Bin [5 ]
机构
[1] Harbin Med Univ, Affiliated Hosp 3, Dept Abdominal Surg, Harbin 150040, Heilongjiang Pr, Peoples R China
[2] Harbin Med Univ, Hosp 5, Dept Gen Surg, Harbin 150040, Heilongjiang Pr, Peoples R China
[3] Nanfang Hosp, Dept Gen Surg, Guangzhou 510515, Guangdong, Peoples R China
[4] Harbin Med Univ, Affiliated Hosp 2, Dept Geriatr, Harbin 150096, Heilongjiang Pr, Peoples R China
[5] Harbin Med Univ, Dept Mol Biol, Harbin 150057, Heilongjiang Pr, Peoples R China
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To observe the reversal effects of wide-type p53 gene on multi-drug resistance to 5-FU (LOVO/5-FU). METHODS: After treatment with Ad-p53, LOVO/5-FU sensitivity to 5-Fu was investigated using tetrazolium dye assay. Multidrug resistance gene-1 (MDR1) gene expression was assayed by semi-quantitative reverse transcription-polymerase chain reaction and the expression of p53 protein was examined by Western blotting. RESULTS: The reversal activity after treatment with wide-type p53 gene was increased up to 4.982 fold at 48 h. The expression of MDR1 gene decreased significantly after treatment with wide-type p53 gene, and the expression of p53 protein lasted for about 5 d, with a peak at 48 h, and began to decrease at 72 h. CONCLUSION: Wide-type p53 gene has a remarkable reversal activity for the high expression of MDR1 gene in colorectal cancers. The reversal effects seem to be in a time dependent manner. It might have good prospects in clinical application.
引用
收藏
页码:1979 / 1983
页数:5
相关论文
共 38 条
[1]
A role for P-glycoprotein in environmental toxicology [J].
Abu-Qare, AW ;
Elmasry, E ;
Abou-Donia, MB .
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART B-CRITICAL REVIEWS, 2003, 6 (03) :279-288
[2]
SUPPRESSION OF HUMAN COLORECTAL-CARCINOMA CELL-GROWTH BY WILD-TYPE-P53 [J].
BAKER, SJ ;
MARKOWITZ, S ;
FEARON, ER ;
WILLSON, JKV ;
VOGELSTEIN, B .
SCIENCE, 1990, 249 (4971) :912-915
[3]
BORELLINI F, 1993, J BIOL CHEM, V268, P7923
[4]
Regulation of the Mdr1 isoforms in a p53-deficient mouse model [J].
Bush, JA ;
Li, G .
CARCINOGENESIS, 2002, 23 (10) :1603-1607
[5]
Molecular determinants of terminal growth arrest induced in tumor cells by a chemotherapeutic agent [J].
Chang, BD ;
Swift, ME ;
Shen, M ;
Fang, J ;
Broude, EV ;
Roninson, IB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (01) :389-394
[6]
MODULATION OF ACTIVITY OF THE PROMOTER OF THE HUMAN MDR1 GENE BY RAS AND P53 [J].
CHIN, KV ;
UEDA, K ;
PASTAN, I ;
GOTTESMAN, MM .
SCIENCE, 1992, 255 (5043) :459-462
[7]
CRYSTAL-STRUCTURE OF A P53 TUMOR-SUPPRESSOR DNA COMPLEX - UNDERSTANDING TUMORIGENIC MUTATIONS [J].
CHO, YJ ;
GORINA, S ;
JEFFREY, PD ;
PAVLETICH, NP .
SCIENCE, 1994, 265 (5170) :346-355
[8]
REVERSAL OF DRUG-RESISTANCE IN MULTIPLE-MYELOMA WITH VERAPAMIL [J].
DURIE, BGM ;
DALTON, WS .
BRITISH JOURNAL OF HAEMATOLOGY, 1988, 68 (02) :203-206
[9]
Elkeles A, 1999, MOL CELL BIOL, V19, P2594
[10]
EPSTEIN J, 1989, BLOOD, V74, P913